Israelis Outraged After Govt Sent Vital Arrow Missiles To Germany Mid-Iran War There's growing outrage and political division in Israel after news emerged that the government and defense ministry fulfilled a weapons contract with Germany, sending vital Arrow air defense missiles to Berlin during the middle of the Iran war . At the very moment the missiles were being delivered, Israeli citizens wer...
Israelis Outraged After Govt Sent Vital Arrow Missiles To Germany Mid-Iran War There's growing outrage and political division in Israel after news emerged that the government and defense ministry fulfilled a weapons contract with Germany, sending vital Arrow air defense missiles to Berlin during the middle of the Iran war . At the very moment the missiles were being delivered, Israeli citizens were dying under Iran's fierce ballistic missile retaliation attacks during the height of Operation Epic Fury. Source: Israel Aerospace Industries/UPI The Jerusalem Post has "confirmed that Israel continued to send Arrow missiles to Berlin mid-war as part of a contract between the countries, even though Israel had a shortage of its own interceptors," the publication writes. "Some commentators upon learning this information have accused the Israeli government of allowing at least five persons to die and hundreds to be injured when the IDF did not use the Arrow to defend from certain attacks ," the report adds. The Arrow was developed jointly with the United States and is designed to intercept long-range missiles, serving as the highest tier of Israel's multi-layered defense . The first Arrow was delivered to Germany in 2025, despite that starting with the last June war, it has been an open secret that Israel is running low on interceptors , and that it takes a significant amount of time to replenish them. In April, we featured analysis describing how Israel only in the last few years grew to become Germany's largest arms partner in a 'mega deal' : Israel’s delivery of the Arrow 3 missile defense system to Germany last year, which was its largest export deal ever at $4.6 billion , led to its share of Germany’s arms imports jumping from 13% during the period 2020-2024 to 55% during the period 2021-2025. At the same time, Israel remained Germany’s third-largest arms client at 10% of its exports from 2021-2025 compared to 11% of them from 2020-2024, with the slight 1% decrease like...
UBS Group AG Chief Executive Officer Sergio Ermotti said that financial markets are at risk of over-optimism regarding the Iran conflict. “The expectation is not only that things are going to be resolved which we believe and hope — but the impact of what happened will be resolved in a classical way,” Ermotti said in a Bloomberg TV interview with Guy Johnson. Investors have seen multiple “V-shaped”...
UBS Group AG Chief Executive Officer Sergio Ermotti said that financial markets are at risk of over-optimism regarding the Iran conflict. “The expectation is not only that things are going to be resolved which we believe and hope — but the impact of what happened will be resolved in a classical way,” Ermotti said in a Bloomberg TV interview with Guy Johnson. Investors have seen multiple “V-shaped” recoveries in recent years where things return to normal, Ermotti said. Yet now, governments don’t have a lot of room to boost growth, he said. Equity markets have risen to record highs even though the conflict in Iran has been escalating without a sustainable solution on the horizon. “The market is quite optimistic and hopefully it’s going to be that way,” he said, touting diversification as a way to insure against reversals. UBS is the largest global wealth manager, with some $6.9 trillion in invested client assets. Ermotti also commented on the new Swiss capital regime which is now making its way into parliament. Ermotti refuted notions that UBS is lobbying hard to influence lawmakers in Switzerland to water down the requirements. Read More: Swiss Minister Says Lawmakers Fear UBS Will Cut Party Funding “We are not lobbying hard,” he said. “We are just representing the interests” of shareholders. “We are just trying to contribute to a fact based discussion,”he added. “We are not asking for anything other than having something that is internationally aligned. And allow us to compete out of Switzerland in a fair way.” Read More: UBS Faces $20 Billion Hike in Capital Needs as Swiss Split Grows
AstraZeneca PLC press release ( AZN ): Q1 Non-GAAP EPS of $2.58 beats by $1.31 . Revenue of $15.29B (+12.5% Y/Y) beats by $370M . Core operating profit increased 12%. Core tax rate of 21%. Expectations for full year Core Tax rate are unchanged at 18-22%. Guidance: AstraZeneca reconfirms total revenue and core EPS guidance for FY 2026 at CER, based on the average foreign exchange rates through 2025...
AstraZeneca PLC press release ( AZN ): Q1 Non-GAAP EPS of $2.58 beats by $1.31 . Revenue of $15.29B (+12.5% Y/Y) beats by $370M . Core operating profit increased 12%. Core tax rate of 21%. Expectations for full year Core Tax rate are unchanged at 18-22%. Guidance: AstraZeneca reconfirms total revenue and core EPS guidance for FY 2026 at CER, based on the average foreign exchange rates through 2025. Total revenue is expected to increase by a mid-to-high single-digit percentage vs. estimated growth of 7.56% Y/Y . Core EPS is expected to increase by a low double-digit percentage vs. estimated growth of 12.04% Y/Y . The core tax rate is expected to be between 18% and 22%. More on AstraZeneca PLC AstraZeneca: The Bigger Picture Remains Solid Growth Amidst Improving Margins And Returns AstraZeneca: The Big China Bet AstraZeneca: Q4 Earnings Analysis - Ticks The Boxes, Upgrading To Buy Amgen, Astra launch real-time trials as FDA to expedite drug development using AI AstraZeneca’s Breztri wins U.S. approval for asthma treatment